Lipidil and Avapro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lipidil (fenofibrate) and Avapro (irbesartan). Common drug interactions include renal failure among females and weight decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Lipidil and Avapro. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Lipidil?

Lipidil has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 2,699 Lipidil users. Check the latest studies of Lipidil.

What is Avapro?

Avapro has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 19,840 Avapro users. Check the latest studies of Avapro.



On Jul, 09, 2026

41 people who take Lipidil and Avapro together, and have interactions are studied.

Lipidil and Avapro drug interactions.

What are the common drug interactions of Lipidil and Avapro, by gender? *:

female:

  1. Renal failure (kidney dysfunction)
  2. Renal impairment (severely reduced kidney function)
  3. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  4. Type 2 diabetes mellitus
  5. Urine flow decreased
  6. Urine output decreased
  7. Vaccination site swelling
  8. Vomiting
  9. Nausea (feeling of having an urge to vomit)
  10. Arthralgia (joint pain)

male:

  1. Weight decreased
  2. Abdominal adhesions (inflammation of abdomen)
  3. Vomiting
  4. Adhesion
  5. Blood pressure decreased
  6. Bradycardia (abnormally slow heart action)
  7. Confusional state
  8. Hypoglycaemia (deficiency of glucose in the bloodstream)
  9. Nausea (feeling of having an urge to vomit)
  10. Renal failure acute (rapid kidney dysfunction)

What are the common drug interactions of Lipidil and Avapro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Generalised oedema (swelling all over the body)
  2. Haemorrhage subcutaneous (bleeding from skin)

50-59:

  1. Infection
  2. Respiratory tract infection
  3. Cardiac disorder
  4. Renal failure (kidney dysfunction)
  5. Vaccination site swelling
  6. Drug ineffective
  7. Pain
  8. Nausea (feeling of having an urge to vomit)
  9. Arthralgia (joint pain)
  10. Back pain

60+:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Blood glucose increased
  3. Nausea (feeling of having an urge to vomit)
  4. Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Anaemia (lack of blood)
  7. Arthralgia (joint pain)
  8. Blood glucose decreased
  9. Cardiac tamponade (fluid accumulates in heart covering)
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the existing conditions these people have? *

  1. Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 14.63%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 12.20%
  3. Diabetes: 5 people, 12.20%
  4. Type 2 Diabetes: 4 people, 9.76%
  5. Osteoporosis (bones weak and more likely to break): 4 people, 9.76%
  6. Depression: 4 people, 9.76%
  7. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 7.32%
  8. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 3 people, 7.32%
  9. Pain: 3 people, 7.32%
  10. Intervertebral Disc Degeneration (spinal disc degeneration): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Lipidil and Avapro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lipidil and Avapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lipidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Avapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lipidil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Avapro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate and irbesartan (the active ingredients of Lipidil and Avapro, respectively), and Lipidil and Avapro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: